Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Key pathophysiologic mechanisms include: Mucosal barrier dysfunction: Impaired epithelial tight junctions allow bacterial translocation, triggering innate immune activation T-helper cell dysregulation: Predominantly Th1 and Th17 pathways drive chronic inflammation via TNF-, IL-12, IL-23 the basis for biologic therapy targets Transmural inflammation: Unlike UC (mucosal only), CD involves all layers: mucosa submucosa muscularis propria serosa Granuloma formation: Non-caseating granulomas are pathognomonic but present in only ~3050% of biopsies Fibrosis and stricture: Chronic inflammation activates myofibroblasts collagen deposition luminal narrowing obstructive symptoms Fistula formation: Transmural ulcers penetrate serosa form sinus tracts connect to adjacent bowel, bladder, vagina, or skin 7
Everything not mentioned in the itinerary is included
Food and Drug Administration (FDA) for any purpose
This is determined by a variety of factors including individual metabolism, overall health, and the severity of any existing B12 deficiency
10.24875/RIC.20000208 59 Vidal-AlaballJ.ButlerC
determining the required liquid volume
US$ 26.18
US$ 20.08
US$ 25.85
US$ 29.21
